oncodaily.com/blog/islb-25...
#Cancer #InternationalSocietyOfLiquidBiopsy #ISLB #LiquidBiopsy #OncoDaily #Oncologist #Medicine #Health #AttitudesAndPractices #Oncology
oncodaily.com/blog/islb-25...
#Cancer #InternationalSocietyOfLiquidBiopsy #ISLB #LiquidBiopsy #OncoDaily #Oncologist #Medicine #Health #AttitudesAndPractices #Oncology
No better way to celebrate the beginning of this event than with a picture of the president of ISLB @christianrolfo.bsky.social and the secretary of ISLB @umbertomalapelle
Ready to kick of! 🩸🧬
No better way to celebrate the beginning of this event than with a picture of the president of ISLB @christianrolfo.bsky.social and the secretary of ISLB @umbertomalapelle
Ready to kick of! 🩸🧬
@christianrolfo.bsky.social
oncodaily.com/voices/islb-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ISLB #ISLB2025
@christianrolfo.bsky.social
oncodaily.com/voices/islb-...
#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ISLB #ISLB2025
💥 Visit our Booth #12041 and get a chance to win a FREE ISLB Membership!
🇺🇸 Visit ISLB Booth
🇪🇸 Visita el stand de ISLB
🇫🇷 Venez au stand ISLB
🇧🇷 Visite o estande da ISLB
🇮🇹 Visita lo stand ISLB
🇩🇪 Besuchen Sie den ISLB-Stand
🇨🇳 访问 ISLB 展位
📅 May 30 – June 3, 2025
💥 Visit our Booth #12041 and get a chance to win a FREE ISLB Membership!
🇺🇸 Visit ISLB Booth
🇪🇸 Visita el stand de ISLB
🇫🇷 Venez au stand ISLB
🇧🇷 Visite o estande da ISLB
🇮🇹 Visita lo stand ISLB
🇩🇪 Besuchen Sie den ISLB-Stand
🇨🇳 访问 ISLB 展位
📅 May 30 – June 3, 2025
Visionary liquid biopsy expert @christianrolfo.bsky.social gives master class lectures on translational potential for innovative LB technologies & approaches 💯💯
@osucccjames.bsky.social @osuwexmed.bsky.social
🔑 message
ctDNA fragmentation is emerging as a new tool to better understand and use LB in the management of cancer patients!
@umbertomalapelle1
@stoverlab.bsky.social
Visionary liquid biopsy expert @christianrolfo.bsky.social gives master class lectures on translational potential for innovative LB technologies & approaches 💯💯
@osucccjames.bsky.social @osuwexmed.bsky.social
🙏 @leukocytebiology.bsky.social
Full piece👇
🙏 @leukocytebiology.bsky.social
Full piece👇
Join the global liquid biopsy community in Madrid for the 8th Annual Congress of Liquid Biopsy.
Register by 2 October 2026 to save with Early Bird rates.
islb-congress.info
#ISLB2026 #LiquidBiopsy #CancerResearch #PrecisionOncology
Join the global liquid biopsy community in Madrid for the 8th Annual Congress of Liquid Biopsy.
Register by 2 October 2026 to save with Early Bird rates.
islb-congress.info
#ISLB2026 #LiquidBiopsy #CancerResearch #PrecisionOncology
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
The ISLB has just published a perspective article about Minimal requirement for ctDNA analysis.
🔗 Read the full article here
www.journalofliquidbiopsy.com/article/S295...
#LiquidBiopsy #Oncology #PrecisionMedicine #ISLB24 @christianrolfo.bsky.social @oncoalert.bsky.social
#LiquidBiopsy #Oncology #PrecisionMedicine #ISLB24 @christianrolfo.bsky.social @oncoalert.bsky.social
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social
@christianrolfo.bsky.social @rolfolab.bsky.social @oncoalert.bsky.social
The ISLB created this survey to understand how to improve the use of #liquidbiopsy in clinical oncology!
Don't miss the opportunity to shape the future of LB in cancer patients!! 🔥
@christianrolfo.bsky.social @robertoboreamd.bsky.social
Oncologist Attitudes and Practices on Liquid Biopsy
👉 https://buff.ly/3Cvf8BJ
This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.
The ISLB created this survey to understand how to improve the use of #liquidbiopsy in clinical oncology!
Don't miss the opportunity to shape the future of LB in cancer patients!! 🔥
@christianrolfo.bsky.social @robertoboreamd.bsky.social
Congratulations! 🚀
Congratulations! 🚀
Your input is crucial to identify key opportunities and issues in our daily practice and share them with stakeholders and the scientific community.
Join us 👇
Your input is crucial to identify key opportunities and issues in our daily practice and share them with stakeholders and the scientific community.
Join us 👇
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
303 participants,
24 countries 🌎
100 abstracts 📝
50 speakers 👨🏫👩🏫
26 travel awards ✈️
3 ISLB awards🥇
32 sponsors
5 satellite symposium ✏️
THAKS ALL OF YOU “THE” INTERNATIONAL LIQUID BIOPSY SOCIETY IS GROWING EVERY YEAR ! @isliquidbiopsy
303 participants,
24 countries 🌎
100 abstracts 📝
50 speakers 👨🏫👩🏫
26 travel awards ✈️
3 ISLB awards🥇
32 sponsors
5 satellite symposium ✏️
THAKS ALL OF YOU “THE” INTERNATIONAL LIQUID BIOPSY SOCIETY IS GROWING EVERY YEAR ! @isliquidbiopsy
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
Read more: doi.org/10.1016/j.crit…#LiquidBiopsysy
@christianrolfo.bsky.social
Let’s advance precision care for medical oncologists together! 🩺🔬
@christianrolfo.bsky.social @rolfolab.bsky.social
Oncologist Attitudes and Practices on Liquid Biopsy
👉 https://buff.ly/3Cvf8BJ
This survey aims to evaluate oncologists' attitudes, practices, and barriers to the use of liquid biopsy in clinical care.
Let’s advance precision care for medical oncologists together! 🩺🔬
@christianrolfo.bsky.social @rolfolab.bsky.social
Chairs Eloisa Jantus Lewintre & Paul Hofman are joined by Mev Dominguez-Valentin, Manuel Ottaviano, Marc Van den Bulcke & Klaus Pantel.
📍 Madrid | 7–9 Nov 2026
🔗 islb-congress.info
#CancerResearch #PrecisionOncology #LiquidBiopsy
Chairs Eloisa Jantus Lewintre & Paul Hofman are joined by Mev Dominguez-Valentin, Manuel Ottaviano, Marc Van den Bulcke & Klaus Pantel.
📍 Madrid | 7–9 Nov 2026
🔗 islb-congress.info
#CancerResearch #PrecisionOncology #LiquidBiopsy
At #ISLB2026, leaders from PREDI-LYNCH, SPARC, JA-PCM & GUIDE.MRD will explore clinical validation, MRD monitoring and equitable implementation across Europe.
𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 & 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫 → islb-congress.info
#LiquidBiopsy #CancerResearch
At #ISLB2026, leaders from PREDI-LYNCH, SPARC, JA-PCM & GUIDE.MRD will explore clinical validation, MRD monitoring and equitable implementation across Europe.
𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞 & 𝐫𝐞𝐠𝐢𝐬𝐭𝐞𝐫 → islb-congress.info
#LiquidBiopsy #CancerResearch
Together, we can make a difference and pave the way for a future free from cancer.
@christianrolfo.bsky.social
Together, we can make a difference and pave the way for a future free from cancer.
@christianrolfo.bsky.social